Retinal fundus imaging and OCT imaging for ocular detection of ATTR-CM

Study identifier:D8455R00001

ClinicalTrials.gov identifier:NCT07690436

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

A Multicenter Pilot Study to Investigate Ocular Involvement and the Potential of Ocular Imaging for Non-invasive Screening for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Medical condition

Transthyretin Amyloid Cardiomyopathy

Phase

-

Healthy volunteers

no

Study drug

-

Sex

All

Estimated Enrollment

500

Study type

Observational

Age

18 Years +

Date

Study Start Date: 02 Jul 2026
Estimated Primary Completion Date: 03 Jun 2027
Estimated Study Completion Date: 03 Jun 2027

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jul 2026 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria